S. Stawicki

发表

Structural studies of neuropilin/antibody complexes provide insights into semaphorin and VEGF binding

Christian Wiesmann, Ping Wu, M. Tessier-Lavigne, 2007, The EMBO journal.

Antibody-based targeting of FGFR3 in bladder carcinoma and t(4;14)-positive multiple myeloma in mice.

Christian Wiesmann, Pamela Chan, Ping Wu, 2009, The Journal of clinical investigation.

Blocking neuropilin-2 function inhibits tumor cell metastasis.

F. Peale, M. Tessier-Lavigne, I. Kasman, 2008, Cancer cell.

Evaluation of X-ray properties of 3 D printing materials for preclinical Positron Emission Tomography / Computed Tomography ( PET / CT ) phantom development

D. Seshasayee, Hoil Kang, Kellen Schneider, 2017 .

Wnt Isoform-Specific Interactions with Coreceptor Specify Inhibition or Potentiation of Signaling by LRP6 Antibodies

E. Bourhis, R. Carano, R. Hannoush, 2010, PloS one.

Mechanistic analysis of RNA synthesis by RNA-dependent RNA polymerase from two promoters reveals similarities to DNA-dependent RNA polymerase.

R. W. Siegel, C. Kao, S. Adkins, 1998, RNA.

InhibitionofDll4signallinginhibitstumourgrowthby deregulating angiogenesis

J. Ridgway, Minhong Yan, G. Plowman, 2006 .

MR angiogenesis imaging with Robo4- vs. (cid:1) V (cid:2) 3 -targeted nanoparticles in a B16/F10 mouse melanoma model

S. Caruthers, R. Carano, S. Stawicki, 2011 .

Systematic pharmacological analysis of agonistic and antagonistic fibroblast growth factor receptor 1 MAbs reveals a similar unique mode of action

G. Schaefer, J. Chan, M. Hafner, 2022, The Journal of biological chemistry.

Blocking neuropilin-1 function has an additive effect with anti-VEGF to inhibit tumor growth.

Franklin Peale, Judy Mak, Qi Pan, 2007, Cancer cell.

Spatial Perturbations within an RNA Promoter Specifically Recognized by a Viral RNA-Dependent RNA Polymerase (RdRp) Reveal That RdRp Can Adjust Its Promoter Binding Sites

C. Kao, S. Stawicki, 1999, Journal of Virology.

Blocking NRG1 and Other Ligand-Mediated Her4 Signaling Enhances the Magnitude and Duration of the Chemotherapeutic Response of Non–Small Cell Lung Cancer

R. Carano, E. Jackson, G. Schaefer, 2013, Science Translational Medicine.

Therapeutic antibody targeting of individual Notch receptors

Thijs J. Hagenbeek, J. Zha, J. Ridgway, 2010, Nature.

Therapeutic antibodies reveal Notch control of transdifferentiation in the adult lung

Christian A. Siltanen, J. Egen, Yvonne Chinn, 2015, Nature.

Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis

Minhong Yan, I. Kasman, Mallika Singh, 2006, Nature.

PirB is a Functional Receptor for Myelin Inhibitors of Axonal Regeneration

C. Shatz, M. Tessier-Lavigne, J. Syken, 2008, Science.

The trimeric serine protease HtrA1 forms a cage-like inhibition complex with an anti-HtrA1 antibody.

M. van Lookeren Campagne, A. Estevez, C. Ciferri, 2015, The Biochemical journal.

Robo4 maintains vessel integrity and inhibits angiogenesis by interacting with UNC5B.

F. Peale, M. Tessier-Lavigne, A. Eichmann, 2011, Developmental cell.

Amelioration of Type 2 Diabetes by Antibody-Mediated Activation of Fibroblast Growth Factor Receptor 1

Jun Li, Anne Wong, N. van Bruggen, 2011, Science Translational Medicine.

An anti-Axl monoclonal antibody attenuates xenograft tumor growth and enhances the effect of multiple anticancer therapies

R. Weimer, D. Kallop, J. Eastham‐Anderson, 2010, Oncogene.

Structural and Functional Analysis of a C3b-specific Antibody That Selectively Inhibits the Alternative Pathway of Complement*

M. van Lookeren Campagne, P. Hass, Jianping Yin, 2009, Journal of Biological Chemistry.

A two-in-one antibody against HER3 and EGFR has superior inhibitory activity compared with monospecific antibodies.

M. Sliwkowski, D. Danilenko, C. Eigenbrot, 2011, Cancer cell.

MR angiogenesis imaging with Robo4‐ vs. αVβ3‐targeted nanoparticles in a B16/F10 mouse melanoma model

S. Caruthers, R. Carano, S. Stawicki, 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Ai-Luen Wu Fibroblast Growth Factor Receptor 1 Amelioration of Type 2 Diabetes by Antibody-Mediated Activation of

Jun Li, N. Bruggen, A. Peterson, 2011 .

Sustained Brown Fat Stimulation and Insulin Sensitization by a Humanized Bispecific Antibody Agonist for Fibroblast Growth Factor Receptor 1/βKlotho Complex

Matthew J. Brauer, N. van Bruggen, M. Brauer, 2015, EBioMedicine.

Structural basis for the dual recognition of helical cytokines IL-34 and CSF-1 by CSF-1R.

M. Starovasnik, J. Bazan, S. Stawicki, 2012, Structure.

Structural insight into distinct mechanisms of protease inhibition by antibodies

D. Kirchhofer, C. Eigenbrot, Wei-Ching Liang, 2007, Proceedings of the National Academy of Sciences.

Function blocking antibodies to neuropilin-1 generated from a designed human synthetic antibody phage library.

M. Tessier-Lavigne, C. Eigenbrot, Jianping Yin, 2007, Journal of molecular biology.

Antibody-based targeting of FGFR3 in bladder carcinoma and t(4;14)-positive multiple myeloma in mice.

D. Dornan, S. Marsters, A. Ashkenazi, 2009, The Journal of clinical investigation.

Structural basis for the dual recognition of helical cytokines IL-34 and CSF-1 by CSF-1R.

M. Starovasnik, S. Stawicki, K. Mukhyala, 2012, Structure.